nodes	percent_of_prediction	percent_of_DWPC	metapath
Exemestane—Methylprednisolone—psoriatic arthritis	0.182	0.357	CrCtD
Exemestane—Prednisone—psoriatic arthritis	0.166	0.326	CrCtD
Exemestane—Prednisolone—psoriatic arthritis	0.162	0.318	CrCtD
Exemestane—CYP19A1—Betamethasone—psoriatic arthritis	0.0634	0.422	CbGbCtD
Exemestane—CYP19A1—Dexamethasone—psoriatic arthritis	0.0369	0.246	CbGbCtD
Exemestane—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0124	0.0823	CbGbCtD
Exemestane—Testolactone—Methylprednisolone—psoriatic arthritis	0.0108	0.0362	CrCrCtD
Exemestane—Testolactone—Dexamethasone—psoriatic arthritis	0.0106	0.0356	CrCrCtD
Exemestane—Testolactone—Betamethasone—psoriatic arthritis	0.0106	0.0356	CrCrCtD
Exemestane—Testolactone—Triamcinolone—psoriatic arthritis	0.0103	0.0348	CrCrCtD
Exemestane—Testolactone—Prednisone—psoriatic arthritis	0.00982	0.033	CrCrCtD
Exemestane—Prednisone—Methylprednisolone—psoriatic arthritis	0.00963	0.0324	CrCrCtD
Exemestane—Testolactone—Prednisolone—psoriatic arthritis	0.00958	0.0322	CrCrCtD
Exemestane—Prednisone—Dexamethasone—psoriatic arthritis	0.00948	0.0319	CrCrCtD
Exemestane—Prednisone—Betamethasone—psoriatic arthritis	0.00948	0.0319	CrCrCtD
Exemestane—CYP3A4—Triamcinolone—psoriatic arthritis	0.00936	0.0624	CbGbCtD
Exemestane—Prednisone—Triamcinolone—psoriatic arthritis	0.00926	0.0312	CrCrCtD
Exemestane—Fluprednidene Acetate—Methylprednisolone—psoriatic arthritis	0.00894	0.0301	CrCrCtD
Exemestane—Loteprednol—Methylprednisolone—psoriatic arthritis	0.00894	0.0301	CrCrCtD
Exemestane—Fluprednidene Acetate—Dexamethasone—psoriatic arthritis	0.0088	0.0296	CrCrCtD
Exemestane—Fluprednidene Acetate—Betamethasone—psoriatic arthritis	0.0088	0.0296	CrCrCtD
Exemestane—Loteprednol—Dexamethasone—psoriatic arthritis	0.0088	0.0296	CrCrCtD
Exemestane—Loteprednol—Betamethasone—psoriatic arthritis	0.0088	0.0296	CrCrCtD
Exemestane—Loteprednol—Triamcinolone—psoriatic arthritis	0.0086	0.0289	CrCrCtD
Exemestane—Fluprednidene Acetate—Triamcinolone—psoriatic arthritis	0.0086	0.0289	CrCrCtD
Exemestane—Prednisone—Prednisolone—psoriatic arthritis	0.00858	0.0289	CrCrCtD
Exemestane—Methylprednisolone—Dexamethasone—psoriatic arthritis	0.00823	0.0277	CrCrCtD
Exemestane—Methylprednisolone—Betamethasone—psoriatic arthritis	0.00823	0.0277	CrCrCtD
Exemestane—Prednisolone—Methylprednisolone—psoriatic arthritis	0.00818	0.0275	CrCrCtD
Exemestane—Fluprednidene Acetate—Prednisone—psoriatic arthritis	0.00816	0.0275	CrCrCtD
Exemestane—Loteprednol—Prednisone—psoriatic arthritis	0.00816	0.0275	CrCrCtD
Exemestane—Prednisolone—Dexamethasone—psoriatic arthritis	0.00805	0.0271	CrCrCtD
Exemestane—Prednisolone—Betamethasone—psoriatic arthritis	0.00805	0.0271	CrCrCtD
Exemestane—Methylprednisolone—Triamcinolone—psoriatic arthritis	0.00804	0.027	CrCrCtD
Exemestane—CYP3A4—Betamethasone—psoriatic arthritis	0.00803	0.0535	CbGbCtD
Exemestane—Fluprednidene Acetate—Prednisolone—psoriatic arthritis	0.00797	0.0268	CrCrCtD
Exemestane—Loteprednol—Prednisolone—psoriatic arthritis	0.00797	0.0268	CrCrCtD
Exemestane—CYP3A4—Prednisolone—psoriatic arthritis	0.00792	0.0528	CbGbCtD
Exemestane—Prednisolone—Triamcinolone—psoriatic arthritis	0.00787	0.0265	CrCrCtD
Exemestane—Methylprednisolone—Prednisone—psoriatic arthritis	0.00763	0.0257	CrCrCtD
Exemestane—CYP3A4—Prednisone—psoriatic arthritis	0.00748	0.0499	CbGbCtD
Exemestane—Prednisolone—Prednisone—psoriatic arthritis	0.00747	0.0251	CrCrCtD
Exemestane—Methylprednisolone—Prednisolone—psoriatic arthritis	0.00745	0.025	CrCrCtD
Exemestane—Testosterone—Prednisolone—psoriatic arthritis	0.00745	0.025	CrCrCtD
Exemestane—CYP3A4—Dexamethasone—psoriatic arthritis	0.00467	0.0311	CbGbCtD
Exemestane—Myocardial infarction—Dexamethasone—psoriatic arthritis	8.99e-05	0.00216	CcSEcCtD
Exemestane—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	8.99e-05	0.00216	CcSEcCtD
Exemestane—Cerebrovascular accident—Methotrexate—psoriatic arthritis	8.84e-05	0.00212	CcSEcCtD
Exemestane—Sweating increased—Prednisone—psoriatic arthritis	8.72e-05	0.00209	CcSEcCtD
Exemestane—Visual impairment—Methylprednisolone—psoriatic arthritis	8.72e-05	0.00209	CcSEcCtD
Exemestane—Osteoarthritis—Methotrexate—psoriatic arthritis	8.66e-05	0.00208	CcSEcCtD
Exemestane—Cardiac disorder—Methylprednisolone—psoriatic arthritis	8.4e-05	0.00202	CcSEcCtD
Exemestane—Haemoglobin—Dexamethasone—psoriatic arthritis	8.27e-05	0.00199	CcSEcCtD
Exemestane—Haemoglobin—Betamethasone—psoriatic arthritis	8.27e-05	0.00199	CcSEcCtD
Exemestane—Haemorrhage—Dexamethasone—psoriatic arthritis	8.23e-05	0.00198	CcSEcCtD
Exemestane—Haemorrhage—Betamethasone—psoriatic arthritis	8.23e-05	0.00198	CcSEcCtD
Exemestane—Immune system disorder—Methylprednisolone—psoriatic arthritis	8.17e-05	0.00196	CcSEcCtD
Exemestane—Weight increased—Prednisone—psoriatic arthritis	8.15e-05	0.00196	CcSEcCtD
Exemestane—Depression—Prednisone—psoriatic arthritis	7.96e-05	0.00191	CcSEcCtD
Exemestane—Visual impairment—Dexamethasone—psoriatic arthritis	7.93e-05	0.0019	CcSEcCtD
Exemestane—Visual impairment—Betamethasone—psoriatic arthritis	7.93e-05	0.0019	CcSEcCtD
Exemestane—Mental disorder—Methylprednisolone—psoriatic arthritis	7.93e-05	0.0019	CcSEcCtD
Exemestane—Acute coronary syndrome—Prednisone—psoriatic arthritis	7.87e-05	0.00189	CcSEcCtD
Exemestane—Myocardial infarction—Prednisone—psoriatic arthritis	7.83e-05	0.00188	CcSEcCtD
Exemestane—Neuropathy peripheral—Prednisone—psoriatic arthritis	7.83e-05	0.00188	CcSEcCtD
Exemestane—Malaise—Prednisolone—psoriatic arthritis	7.74e-05	0.00186	CcSEcCtD
Exemestane—Back pain—Triamcinolone—psoriatic arthritis	7.64e-05	0.00183	CcSEcCtD
Exemestane—Hypertension—Prednisolone—psoriatic arthritis	7.41e-05	0.00178	CcSEcCtD
Exemestane—Alopecia—Betamethasone—psoriatic arthritis	7.27e-05	0.00175	CcSEcCtD
Exemestane—Alopecia—Dexamethasone—psoriatic arthritis	7.27e-05	0.00175	CcSEcCtD
Exemestane—Haemoglobin—Prednisone—psoriatic arthritis	7.2e-05	0.00173	CcSEcCtD
Exemestane—Haemorrhage—Prednisone—psoriatic arthritis	7.17e-05	0.00172	CcSEcCtD
Exemestane—Malaise—Triamcinolone—psoriatic arthritis	7.12e-05	0.00171	CcSEcCtD
Exemestane—Malaise—Methylprednisolone—psoriatic arthritis	7.1e-05	0.00171	CcSEcCtD
Exemestane—Oedema—Prednisolone—psoriatic arthritis	7.01e-05	0.00168	CcSEcCtD
Exemestane—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	6.96e-05	0.00167	CcSEcCtD
Exemestane—Cough—Triamcinolone—psoriatic arthritis	6.89e-05	0.00165	CcSEcCtD
Exemestane—Hypertension—Triamcinolone—psoriatic arthritis	6.82e-05	0.00164	CcSEcCtD
Exemestane—Hypertension—Methylprednisolone—psoriatic arthritis	6.8e-05	0.00163	CcSEcCtD
Exemestane—Hyperhidrosis—Prednisolone—psoriatic arthritis	6.77e-05	0.00163	CcSEcCtD
Exemestane—Myalgia—Triamcinolone—psoriatic arthritis	6.72e-05	0.00161	CcSEcCtD
Exemestane—Arthralgia—Methylprednisolone—psoriatic arthritis	6.71e-05	0.00161	CcSEcCtD
Exemestane—Myalgia—Methylprednisolone—psoriatic arthritis	6.71e-05	0.00161	CcSEcCtD
Exemestane—Anxiety—Methylprednisolone—psoriatic arthritis	6.68e-05	0.0016	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	6.66e-05	0.0016	CcSEcCtD
Exemestane—Depression—Methotrexate—psoriatic arthritis	6.65e-05	0.0016	CcSEcCtD
Exemestane—Confusional state—Methylprednisolone—psoriatic arthritis	6.48e-05	0.00156	CcSEcCtD
Exemestane—Immune system disorder—Prednisone—psoriatic arthritis	6.47e-05	0.00155	CcSEcCtD
Exemestane—Malaise—Dexamethasone—psoriatic arthritis	6.46e-05	0.00155	CcSEcCtD
Exemestane—Malaise—Betamethasone—psoriatic arthritis	6.46e-05	0.00155	CcSEcCtD
Exemestane—Oedema—Triamcinolone—psoriatic arthritis	6.44e-05	0.00155	CcSEcCtD
Exemestane—Infection—Triamcinolone—psoriatic arthritis	6.4e-05	0.00154	CcSEcCtD
Exemestane—Sweating—Methotrexate—psoriatic arthritis	6.4e-05	0.00154	CcSEcCtD
Exemestane—Infection—Methylprednisolone—psoriatic arthritis	6.39e-05	0.00153	CcSEcCtD
Exemestane—Insomnia—Prednisolone—psoriatic arthritis	6.34e-05	0.00152	CcSEcCtD
Exemestane—Alopecia—Prednisone—psoriatic arthritis	6.33e-05	0.00152	CcSEcCtD
Exemestane—Hepatobiliary disease—Methotrexate—psoriatic arthritis	6.31e-05	0.00152	CcSEcCtD
Exemestane—Nervous system disorder—Methylprednisolone—psoriatic arthritis	6.31e-05	0.00151	CcSEcCtD
Exemestane—Paraesthesia—Prednisolone—psoriatic arthritis	6.29e-05	0.00151	CcSEcCtD
Exemestane—Mental disorder—Prednisone—psoriatic arthritis	6.28e-05	0.00151	CcSEcCtD
Exemestane—Skin disorder—Methylprednisolone—psoriatic arthritis	6.25e-05	0.0015	CcSEcCtD
Exemestane—Hyperhidrosis—Triamcinolone—psoriatic arthritis	6.23e-05	0.0015	CcSEcCtD
Exemestane—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	6.22e-05	0.00149	CcSEcCtD
Exemestane—Hypertension—Betamethasone—psoriatic arthritis	6.19e-05	0.00149	CcSEcCtD
Exemestane—Hypertension—Dexamethasone—psoriatic arthritis	6.19e-05	0.00149	CcSEcCtD
Exemestane—Myalgia—Betamethasone—psoriatic arthritis	6.1e-05	0.00146	CcSEcCtD
Exemestane—Myalgia—Dexamethasone—psoriatic arthritis	6.1e-05	0.00146	CcSEcCtD
Exemestane—Anxiety—Dexamethasone—psoriatic arthritis	6.08e-05	0.00146	CcSEcCtD
Exemestane—Anxiety—Betamethasone—psoriatic arthritis	6.08e-05	0.00146	CcSEcCtD
Exemestane—Haemoglobin—Methotrexate—psoriatic arthritis	6.02e-05	0.00145	CcSEcCtD
Exemestane—Pain—Prednisolone—psoriatic arthritis	5.99e-05	0.00144	CcSEcCtD
Exemestane—Haemorrhage—Methotrexate—psoriatic arthritis	5.99e-05	0.00144	CcSEcCtD
Exemestane—Hepatitis—Methotrexate—psoriatic arthritis	5.99e-05	0.00144	CcSEcCtD
Exemestane—Pharyngitis—Methotrexate—psoriatic arthritis	5.95e-05	0.00143	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	5.87e-05	0.00141	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	5.86e-05	0.00141	CcSEcCtD
Exemestane—Oedema—Dexamethasone—psoriatic arthritis	5.85e-05	0.0014	CcSEcCtD
Exemestane—Oedema—Betamethasone—psoriatic arthritis	5.85e-05	0.0014	CcSEcCtD
Exemestane—Insomnia—Triamcinolone—psoriatic arthritis	5.83e-05	0.0014	CcSEcCtD
Exemestane—Insomnia—Methylprednisolone—psoriatic arthritis	5.82e-05	0.0014	CcSEcCtD
Exemestane—Infection—Dexamethasone—psoriatic arthritis	5.81e-05	0.00139	CcSEcCtD
Exemestane—Infection—Betamethasone—psoriatic arthritis	5.81e-05	0.00139	CcSEcCtD
Exemestane—Paraesthesia—Triamcinolone—psoriatic arthritis	5.79e-05	0.00139	CcSEcCtD
Exemestane—Feeling abnormal—Prednisolone—psoriatic arthritis	5.77e-05	0.00139	CcSEcCtD
Exemestane—Paraesthesia—Methylprednisolone—psoriatic arthritis	5.77e-05	0.00139	CcSEcCtD
Exemestane—Visual impairment—Methotrexate—psoriatic arthritis	5.77e-05	0.00139	CcSEcCtD
Exemestane—Dyspnoea—Triamcinolone—psoriatic arthritis	5.75e-05	0.00138	CcSEcCtD
Exemestane—Nervous system disorder—Betamethasone—psoriatic arthritis	5.73e-05	0.00138	CcSEcCtD
Exemestane—Nervous system disorder—Dexamethasone—psoriatic arthritis	5.73e-05	0.00138	CcSEcCtD
Exemestane—Thrombocytopenia—Dexamethasone—psoriatic arthritis	5.73e-05	0.00137	CcSEcCtD
Exemestane—Thrombocytopenia—Betamethasone—psoriatic arthritis	5.73e-05	0.00137	CcSEcCtD
Exemestane—Dyspepsia—Triamcinolone—psoriatic arthritis	5.67e-05	0.00136	CcSEcCtD
Exemestane—Erythema multiforme—Methotrexate—psoriatic arthritis	5.66e-05	0.00136	CcSEcCtD
Exemestane—Dyspepsia—Methylprednisolone—psoriatic arthritis	5.66e-05	0.00136	CcSEcCtD
Exemestane—Hyperhidrosis—Dexamethasone—psoriatic arthritis	5.65e-05	0.00136	CcSEcCtD
Exemestane—Hyperhidrosis—Betamethasone—psoriatic arthritis	5.65e-05	0.00136	CcSEcCtD
Exemestane—Malaise—Prednisone—psoriatic arthritis	5.63e-05	0.00135	CcSEcCtD
Exemestane—Anorexia—Dexamethasone—psoriatic arthritis	5.57e-05	0.00134	CcSEcCtD
Exemestane—Anorexia—Betamethasone—psoriatic arthritis	5.57e-05	0.00134	CcSEcCtD
Exemestane—Urticaria—Prednisolone—psoriatic arthritis	5.57e-05	0.00134	CcSEcCtD
Exemestane—Cardiac disorder—Methotrexate—psoriatic arthritis	5.56e-05	0.00133	CcSEcCtD
Exemestane—Fatigue—Triamcinolone—psoriatic arthritis	5.56e-05	0.00133	CcSEcCtD
Exemestane—Fatigue—Methylprednisolone—psoriatic arthritis	5.54e-05	0.00133	CcSEcCtD
Exemestane—Pain—Triamcinolone—psoriatic arthritis	5.51e-05	0.00132	CcSEcCtD
Exemestane—Immune system disorder—Methotrexate—psoriatic arthritis	5.41e-05	0.0013	CcSEcCtD
Exemestane—Hypertension—Prednisone—psoriatic arthritis	5.39e-05	0.00129	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	5.33e-05	0.00128	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	5.33e-05	0.00128	CcSEcCtD
Exemestane—Myalgia—Prednisone—psoriatic arthritis	5.31e-05	0.00128	CcSEcCtD
Exemestane—Arthralgia—Prednisone—psoriatic arthritis	5.31e-05	0.00128	CcSEcCtD
Exemestane—Feeling abnormal—Triamcinolone—psoriatic arthritis	5.31e-05	0.00128	CcSEcCtD
Exemestane—Feeling abnormal—Methylprednisolone—psoriatic arthritis	5.3e-05	0.00127	CcSEcCtD
Exemestane—Anxiety—Prednisone—psoriatic arthritis	5.29e-05	0.00127	CcSEcCtD
Exemestane—Alopecia—Methotrexate—psoriatic arthritis	5.29e-05	0.00127	CcSEcCtD
Exemestane—Insomnia—Dexamethasone—psoriatic arthritis	5.29e-05	0.00127	CcSEcCtD
Exemestane—Insomnia—Betamethasone—psoriatic arthritis	5.29e-05	0.00127	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	5.28e-05	0.00127	CcSEcCtD
Exemestane—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	5.26e-05	0.00126	CcSEcCtD
Exemestane—Paraesthesia—Betamethasone—psoriatic arthritis	5.25e-05	0.00126	CcSEcCtD
Exemestane—Paraesthesia—Dexamethasone—psoriatic arthritis	5.25e-05	0.00126	CcSEcCtD
Exemestane—Mental disorder—Methotrexate—psoriatic arthritis	5.25e-05	0.00126	CcSEcCtD
Exemestane—Hypersensitivity—Prednisolone—psoriatic arthritis	5.16e-05	0.00124	CcSEcCtD
Exemestane—Dyspepsia—Betamethasone—psoriatic arthritis	5.15e-05	0.00124	CcSEcCtD
Exemestane—Dyspepsia—Dexamethasone—psoriatic arthritis	5.15e-05	0.00124	CcSEcCtD
Exemestane—Urticaria—Triamcinolone—psoriatic arthritis	5.12e-05	0.00123	CcSEcCtD
Exemestane—Urticaria—Methylprednisolone—psoriatic arthritis	5.11e-05	0.00123	CcSEcCtD
Exemestane—Body temperature increased—Triamcinolone—psoriatic arthritis	5.09e-05	0.00122	CcSEcCtD
Exemestane—Oedema—Prednisone—psoriatic arthritis	5.09e-05	0.00122	CcSEcCtD
Exemestane—Abdominal pain—Methylprednisolone—psoriatic arthritis	5.08e-05	0.00122	CcSEcCtD
Exemestane—Decreased appetite—Dexamethasone—psoriatic arthritis	5.08e-05	0.00122	CcSEcCtD
Exemestane—Decreased appetite—Betamethasone—psoriatic arthritis	5.08e-05	0.00122	CcSEcCtD
Exemestane—Infection—Prednisone—psoriatic arthritis	5.06e-05	0.00121	CcSEcCtD
Exemestane—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	5.05e-05	0.00121	CcSEcCtD
Exemestane—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	5.05e-05	0.00121	CcSEcCtD
Exemestane—Back pain—Methotrexate—psoriatic arthritis	5.04e-05	0.00121	CcSEcCtD
Exemestane—Fatigue—Betamethasone—psoriatic arthritis	5.04e-05	0.00121	CcSEcCtD
Exemestane—Fatigue—Dexamethasone—psoriatic arthritis	5.04e-05	0.00121	CcSEcCtD
Exemestane—Pain—Betamethasone—psoriatic arthritis	5e-05	0.0012	CcSEcCtD
Exemestane—Pain—Dexamethasone—psoriatic arthritis	5e-05	0.0012	CcSEcCtD
Exemestane—Nervous system disorder—Prednisone—psoriatic arthritis	4.99e-05	0.0012	CcSEcCtD
Exemestane—Skin disorder—Prednisone—psoriatic arthritis	4.95e-05	0.00119	CcSEcCtD
Exemestane—Hyperhidrosis—Prednisone—psoriatic arthritis	4.92e-05	0.00118	CcSEcCtD
Exemestane—Anorexia—Prednisone—psoriatic arthritis	4.85e-05	0.00117	CcSEcCtD
Exemestane—Feeling abnormal—Betamethasone—psoriatic arthritis	4.82e-05	0.00116	CcSEcCtD
Exemestane—Feeling abnormal—Dexamethasone—psoriatic arthritis	4.82e-05	0.00116	CcSEcCtD
Exemestane—Gastrointestinal pain—Betamethasone—psoriatic arthritis	4.78e-05	0.00115	CcSEcCtD
Exemestane—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	4.78e-05	0.00115	CcSEcCtD
Exemestane—Hypersensitivity—Triamcinolone—psoriatic arthritis	4.75e-05	0.00114	CcSEcCtD
Exemestane—Hypersensitivity—Methylprednisolone—psoriatic arthritis	4.74e-05	0.00114	CcSEcCtD
Exemestane—Malaise—Methotrexate—psoriatic arthritis	4.7e-05	0.00113	CcSEcCtD
Exemestane—Leukopenia—Methotrexate—psoriatic arthritis	4.67e-05	0.00112	CcSEcCtD
Exemestane—Urticaria—Dexamethasone—psoriatic arthritis	4.65e-05	0.00112	CcSEcCtD
Exemestane—Urticaria—Betamethasone—psoriatic arthritis	4.65e-05	0.00112	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	4.64e-05	0.00111	CcSEcCtD
Exemestane—Dizziness—Prednisolone—psoriatic arthritis	4.63e-05	0.00111	CcSEcCtD
Exemestane—Asthenia—Triamcinolone—psoriatic arthritis	4.62e-05	0.00111	CcSEcCtD
Exemestane—Body temperature increased—Betamethasone—psoriatic arthritis	4.62e-05	0.00111	CcSEcCtD
Exemestane—Abdominal pain—Dexamethasone—psoriatic arthritis	4.62e-05	0.00111	CcSEcCtD
Exemestane—Body temperature increased—Dexamethasone—psoriatic arthritis	4.62e-05	0.00111	CcSEcCtD
Exemestane—Abdominal pain—Betamethasone—psoriatic arthritis	4.62e-05	0.00111	CcSEcCtD
Exemestane—Asthenia—Methylprednisolone—psoriatic arthritis	4.61e-05	0.00111	CcSEcCtD
Exemestane—Insomnia—Prednisone—psoriatic arthritis	4.61e-05	0.00111	CcSEcCtD
Exemestane—Paraesthesia—Prednisone—psoriatic arthritis	4.57e-05	0.0011	CcSEcCtD
Exemestane—Pruritus—Triamcinolone—psoriatic arthritis	4.56e-05	0.00109	CcSEcCtD
Exemestane—Cough—Methotrexate—psoriatic arthritis	4.55e-05	0.00109	CcSEcCtD
Exemestane—Pruritus—Methylprednisolone—psoriatic arthritis	4.55e-05	0.00109	CcSEcCtD
Exemestane—Dyspepsia—Prednisone—psoriatic arthritis	4.48e-05	0.00108	CcSEcCtD
Exemestane—Arthralgia—Methotrexate—psoriatic arthritis	4.44e-05	0.00107	CcSEcCtD
Exemestane—Myalgia—Methotrexate—psoriatic arthritis	4.44e-05	0.00107	CcSEcCtD
Exemestane—Chest pain—Methotrexate—psoriatic arthritis	4.44e-05	0.00107	CcSEcCtD
Exemestane—Decreased appetite—Prednisone—psoriatic arthritis	4.43e-05	0.00106	CcSEcCtD
Exemestane—Rash—Prednisolone—psoriatic arthritis	4.42e-05	0.00106	CcSEcCtD
Exemestane—Dermatitis—Prednisolone—psoriatic arthritis	4.41e-05	0.00106	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	4.41e-05	0.00106	CcSEcCtD
Exemestane—Diarrhoea—Methylprednisolone—psoriatic arthritis	4.4e-05	0.00106	CcSEcCtD
Exemestane—Fatigue—Prednisone—psoriatic arthritis	4.39e-05	0.00105	CcSEcCtD
Exemestane—Headache—Prednisolone—psoriatic arthritis	4.39e-05	0.00105	CcSEcCtD
Exemestane—Constipation—Prednisone—psoriatic arthritis	4.35e-05	0.00105	CcSEcCtD
Exemestane—Confusional state—Methotrexate—psoriatic arthritis	4.29e-05	0.00103	CcSEcCtD
Exemestane—Dizziness—Triamcinolone—psoriatic arthritis	4.26e-05	0.00102	CcSEcCtD
Exemestane—Dizziness—Methylprednisolone—psoriatic arthritis	4.25e-05	0.00102	CcSEcCtD
Exemestane—Infection—Methotrexate—psoriatic arthritis	4.23e-05	0.00102	CcSEcCtD
Exemestane—Feeling abnormal—Prednisone—psoriatic arthritis	4.2e-05	0.00101	CcSEcCtD
Exemestane—Asthenia—Betamethasone—psoriatic arthritis	4.2e-05	0.00101	CcSEcCtD
Exemestane—Asthenia—Dexamethasone—psoriatic arthritis	4.2e-05	0.00101	CcSEcCtD
Exemestane—Nervous system disorder—Methotrexate—psoriatic arthritis	4.17e-05	0.001	CcSEcCtD
Exemestane—Thrombocytopenia—Methotrexate—psoriatic arthritis	4.17e-05	0.001	CcSEcCtD
Exemestane—Gastrointestinal pain—Prednisone—psoriatic arthritis	4.16e-05	0.001	CcSEcCtD
Exemestane—Nausea—Prednisolone—psoriatic arthritis	4.16e-05	0.000999	CcSEcCtD
Exemestane—Pruritus—Betamethasone—psoriatic arthritis	4.14e-05	0.000993	CcSEcCtD
Exemestane—Pruritus—Dexamethasone—psoriatic arthritis	4.14e-05	0.000993	CcSEcCtD
Exemestane—Skin disorder—Methotrexate—psoriatic arthritis	4.13e-05	0.000993	CcSEcCtD
Exemestane—Hyperhidrosis—Methotrexate—psoriatic arthritis	4.11e-05	0.000988	CcSEcCtD
Exemestane—Vomiting—Triamcinolone—psoriatic arthritis	4.1e-05	0.000984	CcSEcCtD
Exemestane—Vomiting—Methylprednisolone—psoriatic arthritis	4.09e-05	0.000982	CcSEcCtD
Exemestane—Rash—Triamcinolone—psoriatic arthritis	4.06e-05	0.000976	CcSEcCtD
Exemestane—Dermatitis—Triamcinolone—psoriatic arthritis	4.06e-05	0.000975	CcSEcCtD
Exemestane—Anorexia—Methotrexate—psoriatic arthritis	4.06e-05	0.000974	CcSEcCtD
Exemestane—Rash—Methylprednisolone—psoriatic arthritis	4.05e-05	0.000973	CcSEcCtD
Exemestane—Dermatitis—Methylprednisolone—psoriatic arthritis	4.05e-05	0.000973	CcSEcCtD
Exemestane—Urticaria—Prednisone—psoriatic arthritis	4.05e-05	0.000971	CcSEcCtD
Exemestane—Headache—Triamcinolone—psoriatic arthritis	4.04e-05	0.000969	CcSEcCtD
Exemestane—Headache—Methylprednisolone—psoriatic arthritis	4.03e-05	0.000967	CcSEcCtD
Exemestane—Body temperature increased—Prednisone—psoriatic arthritis	4.03e-05	0.000967	CcSEcCtD
Exemestane—Abdominal pain—Prednisone—psoriatic arthritis	4.03e-05	0.000967	CcSEcCtD
Exemestane—Diarrhoea—Dexamethasone—psoriatic arthritis	4e-05	0.000961	CcSEcCtD
Exemestane—Diarrhoea—Betamethasone—psoriatic arthritis	4e-05	0.000961	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	3.88e-05	0.000931	CcSEcCtD
Exemestane—Dizziness—Betamethasone—psoriatic arthritis	3.87e-05	0.000928	CcSEcCtD
Exemestane—Dizziness—Dexamethasone—psoriatic arthritis	3.87e-05	0.000928	CcSEcCtD
Exemestane—Insomnia—Methotrexate—psoriatic arthritis	3.85e-05	0.000924	CcSEcCtD
Exemestane—Nausea—Triamcinolone—psoriatic arthritis	3.83e-05	0.000919	CcSEcCtD
Exemestane—Paraesthesia—Methotrexate—psoriatic arthritis	3.82e-05	0.000918	CcSEcCtD
Exemestane—Nausea—Methylprednisolone—psoriatic arthritis	3.82e-05	0.000917	CcSEcCtD
Exemestane—Dyspnoea—Methotrexate—psoriatic arthritis	3.79e-05	0.000911	CcSEcCtD
Exemestane—Hypersensitivity—Prednisone—psoriatic arthritis	3.75e-05	0.000901	CcSEcCtD
Exemestane—Dyspepsia—Methotrexate—psoriatic arthritis	3.75e-05	0.000899	CcSEcCtD
Exemestane—Vomiting—Dexamethasone—psoriatic arthritis	3.72e-05	0.000893	CcSEcCtD
Exemestane—Vomiting—Betamethasone—psoriatic arthritis	3.72e-05	0.000893	CcSEcCtD
Exemestane—Decreased appetite—Methotrexate—psoriatic arthritis	3.7e-05	0.000888	CcSEcCtD
Exemestane—Rash—Betamethasone—psoriatic arthritis	3.69e-05	0.000885	CcSEcCtD
Exemestane—Rash—Dexamethasone—psoriatic arthritis	3.69e-05	0.000885	CcSEcCtD
Exemestane—Dermatitis—Betamethasone—psoriatic arthritis	3.68e-05	0.000884	CcSEcCtD
Exemestane—Dermatitis—Dexamethasone—psoriatic arthritis	3.68e-05	0.000884	CcSEcCtD
Exemestane—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	3.67e-05	0.000882	CcSEcCtD
Exemestane—Fatigue—Methotrexate—psoriatic arthritis	3.67e-05	0.000881	CcSEcCtD
Exemestane—Headache—Dexamethasone—psoriatic arthritis	3.66e-05	0.00088	CcSEcCtD
Exemestane—Headache—Betamethasone—psoriatic arthritis	3.66e-05	0.00088	CcSEcCtD
Exemestane—Asthenia—Prednisone—psoriatic arthritis	3.65e-05	0.000877	CcSEcCtD
Exemestane—Pain—Methotrexate—psoriatic arthritis	3.64e-05	0.000874	CcSEcCtD
Exemestane—Pruritus—Prednisone—psoriatic arthritis	3.6e-05	0.000865	CcSEcCtD
Exemestane—Feeling abnormal—Methotrexate—psoriatic arthritis	3.51e-05	0.000842	CcSEcCtD
Exemestane—Diarrhoea—Prednisone—psoriatic arthritis	3.48e-05	0.000837	CcSEcCtD
Exemestane—Gastrointestinal pain—Methotrexate—psoriatic arthritis	3.48e-05	0.000836	CcSEcCtD
Exemestane—Nausea—Dexamethasone—psoriatic arthritis	3.47e-05	0.000834	CcSEcCtD
Exemestane—Nausea—Betamethasone—psoriatic arthritis	3.47e-05	0.000834	CcSEcCtD
Exemestane—Urticaria—Methotrexate—psoriatic arthritis	3.38e-05	0.000812	CcSEcCtD
Exemestane—Dizziness—Prednisone—psoriatic arthritis	3.37e-05	0.000809	CcSEcCtD
Exemestane—Body temperature increased—Methotrexate—psoriatic arthritis	3.36e-05	0.000808	CcSEcCtD
Exemestane—Abdominal pain—Methotrexate—psoriatic arthritis	3.36e-05	0.000808	CcSEcCtD
Exemestane—Vomiting—Prednisone—psoriatic arthritis	3.24e-05	0.000777	CcSEcCtD
Exemestane—Rash—Prednisone—psoriatic arthritis	3.21e-05	0.000771	CcSEcCtD
Exemestane—Dermatitis—Prednisone—psoriatic arthritis	3.21e-05	0.00077	CcSEcCtD
Exemestane—Headache—Prednisone—psoriatic arthritis	3.19e-05	0.000766	CcSEcCtD
Exemestane—Hypersensitivity—Methotrexate—psoriatic arthritis	3.14e-05	0.000753	CcSEcCtD
Exemestane—Asthenia—Methotrexate—psoriatic arthritis	3.05e-05	0.000733	CcSEcCtD
Exemestane—Nausea—Prednisone—psoriatic arthritis	3.02e-05	0.000726	CcSEcCtD
Exemestane—Pruritus—Methotrexate—psoriatic arthritis	3.01e-05	0.000723	CcSEcCtD
Exemestane—Diarrhoea—Methotrexate—psoriatic arthritis	2.91e-05	0.000699	CcSEcCtD
Exemestane—Dizziness—Methotrexate—psoriatic arthritis	2.81e-05	0.000676	CcSEcCtD
Exemestane—Vomiting—Methotrexate—psoriatic arthritis	2.71e-05	0.00065	CcSEcCtD
Exemestane—Rash—Methotrexate—psoriatic arthritis	2.68e-05	0.000644	CcSEcCtD
Exemestane—Dermatitis—Methotrexate—psoriatic arthritis	2.68e-05	0.000644	CcSEcCtD
Exemestane—Headache—Methotrexate—psoriatic arthritis	2.67e-05	0.00064	CcSEcCtD
Exemestane—Nausea—Methotrexate—psoriatic arthritis	2.53e-05	0.000607	CcSEcCtD
